Sort
16,300 grants matching “fatty liver disease”
Bariatric Surgery Research Consortium
$398,005University Of Washington · U01 · FY2004 · DK
Quantitative characterization of the liver-pancreas axis in diabetes via multiparametric magnetic resonance elastography
$397,974Meng Yin · Mayo Clinic Rochester · R01 · FY2023 · DK
Cardiac Dysfunction in the Met Syndrome: Cross-talk between IR and bAR Signaling
$397,938Evan Dale Abel · University Of Iowa · R01 · FY2015 · HL
Regulation of mitochondrial metabolism by lysine acylation
$397,912Eric S Goetzman · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.
$397,803Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2012 · HD
Sleep Apnea and Dysregulation of Lipid Metabolism
$397,782Vsevolod Y Polotsky · Johns Hopkins University · R01 · FY2014 · HL
Genetics of Type 2 Diabetes
$397,747Swapan Kumar Das · Wake Forest University Health Sciences · R01 · FY2010 · DK
Gut-liver crosstalk by FGF15/19 in regulating xenobiotic nuclear receptor activation
$397,624Grace L Guo · Rutgers, The State Univ Of N.J. · R01 · FY2021 · GM
Investigating the involvement of small intestine in metformin's effect on hepatic lipid metabolism
$397,608Xiaojing Liu · North Carolina State University Raleigh · R35 · FY2023 · GM
Mechanisms of gut microbiota/metabolite interface-mediated hepatic inflammation
$397,590Guangfu Li · University Of Connecticut Sch Of Med/Dnt · R01 · FY2024 · DK
Functions of BNIP3 in lipid metabolism in the liver and in hepatocellular carcinoma
$397,573Kay F Macleod · University Of Chicago · R01 · FY2020 · CA
Functions of BNIP3 in lipid metabolism in the liver and in hepatocellular carcinoma
$397,573Kay F Macleod · University Of Chicago · R01 · FY2017 · CA
Clincal Research Network in Non-Alcoholic Steatohepatitis (NASH CRN)
$397,566Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2013 · DK
Cytoskeletal Regulation Of Vesicle Transport In Liver
$397,500Mark A. Mc Niven · Mayo Clinic Rochester · R56 · FY2022 · DK
Ketogenic oscillations and neurometabolic healthspan
$397,500Peter A Crawford · University Of Minnesota · R01 · FY2020 · AG
Interplay Between Macrophages, Lipid Oxidation and the Nrf2/HO-1 Axis in the Cardiometabolic Toxicity Induced by Ultrafine Particles
$397,402Jesus Antonio Araujo · University Of California Los Angeles · R01 · FY2022 · ES
Lead candidate identification of LPAR1 antagonists for therapeutic application in NASH
$397,398Fabio Cohen Tucci · Epigen Biosciences, Inc. · R43 · FY2021 · DK
Mechanistically based therapeutic strategies in murine primary biliary cholangitis
$397,389Merrill E Gershwin · University Of California At Davis · R01 · FY2022 · DK
Fructose Metabolism as a Biomarker for Monitoring Hepatocellular Carcinoma
$397,258Sui Seng Tee · University Of Maryland Baltimore · R21 · FY2020 · CA
ANGPTL8: function and mechanism of action
$397,255Ren Zhang · Wayne State University · R01 · FY2017 · HL
CSN8 regulation of S1P-enriched extracellular vesicles to modulate NAFLD by gut-liver axis
$397,195Zhong-Bin Deng · University Of Louisville · R01 · FY2021 · DK
Novel Liver Signaling Pathways Controlling Adiposity
$397,165Terry D Hinds · University Of Kentucky · R01 · FY2024 · DK
University of Pittsburgh MACS/WIHS CCS- Supplement Funds from NHLBI
$397,060Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · HL
Oxidation-specific nanoparticles for imaging atherosclerosis
$396,920Sotirios Tsimikas · University Of California, San Diego · R01 · FY2015 · HL
The novel role of FGF21 in mediating sex-dependent responses to dietary macronutrients
$396,915Karen Ryan · University Of California At Davis · R01 · FY2019 · DK